Evidence map›Paper›PMID 41383789›Full record

ArticleCaspian journal of internal medicine2025

Zinc oxide nanoparticles as a new approach to eradicate the biofilm of

Reyhaneh Rezaei Ghamsari, Mohammad Shayestehpour, Ali Sobhani Nasab, Ali Nazari-Alam

Abstract read
In one paragraph

Article in Caspian journal of internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reyhaneh Rezaei GhamsariInfectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Mohammad ShayestehpourDepartment of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Ali Sobhani NasabPhysiology Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
Ali Nazari-AlamInfectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Zinc oxide (ZnO) nanoparticles are particularly notable in the biomedical field, especially for antimicrobial applications, due to their beneficial properties. This study aimed to investigate the antimicrobial activity of ZnO nanoparticles against Methods: A microdilution test was conducted to assess the effectiveness of the synthesized against Results: The minimum inhibitory concentration (MIC) of the ZnO nanocomposite against Conclusion: Overall, ZnO nanoparticles, by reducing the expression levels of the

Indexed as

AntibacterialBiofilmPseudomonas aeruginosaZnO nanoparticles

Identifiers

PMID41383789
PMCPMC12694870

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.